Archive for:
Archives

Under Australian practice, both method of treatment and Swiss-style claims, in the format use of [compound X] in the manufacture of a medicament for the treatment of [condition Y]” are permitted. As reported previously, method of treatment and Swiss-style claims are directed to different infringing acts in Australia. This highlights the importance of pursuing both

Shelston IP has been named a Finalist in the Financial Review Client Choice Awards 2019 for Best IP Specialist Firm. Beaton Research + Consulting, the leading researcher in ‘voice of the client’ services and consultant to professional services, provides the independent research behind the Awards. The survey research for the Client Choice Awards and beatonbenchmarks is

For many manufacturers in Australia, Intellectual Property (IP) can be the most valuable asset the business owns. Why? Because IP can be used in a variety of ways to support a business, writes Greg Whitehead in the latest edition of AMT (Australian Manufacturing Technology) magazine. For many manufacturing businesses in Australia, Intellectual Property (IP)

The more things change, the more they stay the same. New Zealand’s new Patents Act 2013 commenced on 13 September 2014 – and with it, the much-heralded shift from the local novelty standard employed under the Patents Act 1953 to absolute, or worldwide novelty. In this article, we consider what effect this shift is likely

Duncan Longstaff has been named as one of Managing Intellectual Property Rising Stars for 2018. This year’s publication is based on the information obtained during the research period for the 2018 edition of IP STARS (September 2017 to February 2018). Rising stars typically have less than 10 years post-qualification experience but individuals with over